1. 3325 Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study. (September 2015) Authors: Yokota, K.; Takenouchi, T.; Fujimoto, M.; Ihn, H.; Uchi, H.; Inozume, T.; Kiyohara, Y.; Uhara, H.; Nakagawa, K.; Furukawa, H.; Wada, H.; Noguchi, K.; Shimamoto, T.; Yamazaki, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of recurrent squamous cell carcinoma of the vulva successfully treated by combination therapy with cetuximab and paclitaxel. (18th November 2015) Authors: Matsuzawa, M.; Inozume, T.; Sano, S.; Ando, N.; Onuma, T.; Harada, K.; Kawamura, T.; Shimada, S. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A case of recurrent squamous cell carcinoma of the vulva successfully treated by combination therapy with cetuximab and paclitaxel. (1st March 2016) Authors: Matsuzawa, M.; Inozume, T.; Sano, S.; Ando, N.; Onuma, T.; Harada, K.; Kawamura, T.; Shimada, S. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗